One-year outcome with a bovine pericardial valve.

ABSTRACT:

Objectives

To evaluate the safety and effectiveness of a novel surgical bovine pericardial valve for aortic and mitral valve replacements.

Methods

Between March 2016 and October 2017, 197 patients (mean age, 66.9 ± 4.9 years; 40.6% were women) underwent aortic valve replacement and mitral valve replacement and were implanted with the Cingular bovine pericardial valve (Shanghai Cingular Biotech Corporation, Shanghai, China) in a prospective, multicenter, single-arm trial in China. A total of 161 aortic and 49 mitral prostheses were implanted. Patients were followed up to 1 year. The primary end point was the 1-year overall rate of valve-related complications, including thromboembolic event, valve thrombosis, major hemorrhage event, major perivalvular leak, and prosthetic valv

SUBMITTER: Chen J 

PROVIDER: S-EPMC9390642 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature